Print this page    •   Back to Web version of article

International News
Proposed Intellectual Property Agreement Between E.U., India Could Affect Generic Drug Exports, Advocacy Groups Say

February 10, 2012

The Independent examines how "[t]he cheap supply of antiretroviral drugs to people with AIDS across the world could be choked by an 'intellectual property' deal ... being negotiated [on Friday] at the 12th E.U.-India summit in New Delhi between the President of the European Commission, José Manuel Barroso, and the Indian Prime Minister Dr. Manmohan Singh."

AIDS advocacy and treatment organizations say the agreement will "hamper the export of these medicines to the developing world," while "E.U. trade commissioner, Karel De Gucht, has denied this, saying 'any agreement will have no impact on the right or the capacity of India to produce generic medicines,'" the Independent writes. The newspaper notes, "More than 80 percent of those on HIV treatment in developing countries are on generic medicines made in India" and "the country's generics industry is estimated at more than $20 billion (£12 billion), including exports, according to figures quoted in the Lancet last year" (Vallely, 2/10).

Back to other news for February 2012


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/65707/proposed-intellectual-property-agreement-between-e.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.